Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 186

    1.

    Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS.

    Diabetes Care. 2006 Mar;29(3):643-9.PMID: 16505520 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Matheson D, Skyler JS.

    Diabetes Care. 2008 Nov;31(11):2188-92. Epub 2008 Jul 23.PMID: 18650369 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2007 Jan;30(1):38-42.PMID: 17192330 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?

    Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She JX, Greenbaum C, Krischer J.

    Pediatr Diabetes. 2004 Jun;5(2):72-9.PMID: 15189492 [PubMed - indexed for MEDLINE]Related articles

    5.

    Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1.

    Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2009 Sep;32(9):1603-7. Epub 2009 Jun 1.PMID: 19487644 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.

    Faerch K, Vaag A, Holst JJ, Glümer C, Pedersen O, Borch-Johnsen K.

    Diabetologia. 2008 May;51(5):853-61. Epub 2008 Mar 4.PMID: 18317726 [PubMed - indexed for MEDLINE]Related articles

    7.

    Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.

    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.

    Diabetes Care. 2006 Jul;29(7):1613-8.PMID: 16801587 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

    Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2008 Mar;31(3):528-33. Epub 2007 Nov 13.PMID: 18000175 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis.

    Niskanen L, Karjalainen J, Siitonen O, Uusitupa M.

    J Intern Med. 1994 Sep;236(3):263-70.PMID: 8077881 [PubMed - indexed for MEDLINE]Related articles

    10.

    The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients.

    Kim HJ, Ahn CW, Kang ES, Myoung SM, Cha BS, Won YJ, Lim SK, Kim KR, Huh KB, Lee HC.

    J Diabetes Complications. 2007 Jan-Feb;21(1):7-12.PMID: 17189868 [PubMed - indexed for MEDLINE]Related articles

    11.

    Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.

    Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B.

    J Clin Lab Anal. 2007;21(2):85-90.PMID: 17385686 [PubMed - indexed for MEDLINE]Related articles

    12.

    No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

    Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crinò A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G.

    Diabetologia. 2000 Aug;43(8):1000-4.PMID: 10990077 [PubMed - indexed for MEDLINE]Related articles

    13.

    Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.

    Triolo TM, Chase HP, Barker JM; DPT-1 Study Group.

    Diabetes Care. 2009 May;32(5):769-73.PMID: 19407074 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.

    Barker JM, McFann K, Harrison LC, Fourlanos S, Krischer J, Cuthbertson D, Chase HP, Eisenbarth GS; DPT-1 Study Group.

    J Pediatr. 2007 Jan;150(1):31-36.e6.PMID: 17188609 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin secretion in type 1 diabetes.

    Steele C, Hagopian WA, Gitelman S, Masharani U, Cavaghan M, Rother KI, Donaldson D, Harlan DM, Bluestone J, Herold KC.

    Diabetes. 2004 Feb;53(2):426-33.PMID: 14747294 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?

    Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G, Prager R.

    Diabetes Care. 2006 May;29(5):1031-8.PMID: 16644633 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Relationship between gestational diabetes mellitus and type 2 diabetes: evidence of mitochondrial dysfunction.

    Weijers RN, Bekedam DJ.

    Clin Chem. 2007 Mar;53(3):377-83.PMID: 17327503 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.

    Cypryk K, Vilsbøll T, Nadel I, Smyczyńska J, Holst JJ, Lewiński A.

    Gynecol Endocrinol. 2007 Jan;23(1):58-62.PMID: 17484514 [PubMed - indexed for MEDLINE]Related articles

    19.

    Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes.

    Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA.

    Diabetes. 2006 Apr;55(4):1074-9.PMID: 16567531 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effects of raloxifene on insulin sensitivity, beta-cell function, and hepatic insulin extraction in normal postmenopausal women.

    Nagamani M, Szymajda A, Sepilian V, Urban RJ, Gilkison C.

    Fertil Steril. 2008 Mar;89(3):614-9. Epub 2007 Jun 25.PMID: 17586504 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data